Sundia MediTech

About Sundia MediTech

Sundia MediTech was founded in 2004 in Shanghai by Dr. Xiaochuan Wang and a team of seasoned veterans from the US pharmaceutical industry. The company was established as a contract research organization (CRO), providing comprehensive drug discovery and development services to pharmaceutical and biotechnology companies worldwide.

Under the leadership of Dr. Wang, Sundia quickly became a prominent player in the CRO industry, known for its high-quality services and innovative solutions. The company's growth was fueled by its ability to meet the increasing demand for outsourced research and development in the pharmaceutical sector.

In a significant milestone, Sundia MediTech was acquired by BioDuro LLC in 2020. This acquisition marked a new chapter for Sundia, as it joined forces with BioDuro to expand its global reach and enhance its service offerings. The merger created a powerful entity in the life sciences sector, capable of delivering integrated solutions to clients across the globe.

Today, Sundia MediTech continues to thrive as part of BioDuro-Sundia, leveraging its expertise and resources to drive innovation and support the development of new therapies. The company's journey from a startup to a key player in the CRO industry is a testament to the vision and dedication of its founders and team.